Ceesay Abraham Insider Trading Activity
Ceesay Abraham has been net-selling over the last 12 months with 0 purchases and 27 sales across 2 different companies.
RAPP is the most-traded position with 26 trades. The largest single transaction was a sale of RAPP for $1.0M on Sep 17, 2025.
Performance Scorecard
Forward stock performance after each transaction by Ceesay Abraham. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +2.8% | 76% | 25 |
| 90 days | — | -9.5% | 28% | 25 |
| 120 days | — | -17.6% | 12% | 25 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Ceesay Abraham bought and sold RAPP.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 14, 2026 | RAPP | Sell | 2,729 | $40.57 | $111K | −0.5% | CEO | |
Jul 14, 2026 | RAPP | Sell | 5,481 | $39.72 | $218K | −1.0% | CEO | |
Feb 18, 2026 | RAPP | Sell | 2,983 | $29.04 | $87K | −11.6% | CEO | |
Feb 18, 2026 | RAPP | Sell | 2,100 | $29.80 | $63K | −9.2% | CEO | |
Feb 18, 2026 | RAPP | Sell | 3,552 | $29.05 | $103K | −0.6% | CEO | |
Feb 18, 2026 | RAPP | Sell | 2,281 | $29.80 | $68K | −0.4% | CEO | |
Jan 20, 2026 | RAPP | Sell | 5,833 | $26.12 | $152K | −1.0% | CEO | |
Jan 20, 2026 | RAPP | Sell | 5,083 | $26.11 | $133K | −16.5% | CEO | |
Dec 17, 2025 | RAPP | Sell | 600 | $31.04 | $19K | −0.1% | CEO | |
Dec 17, 2025 | RAPP | Sell | 2,147 | $28.84 | $62K | −6.0% | CEO | |
Dec 17, 2025 | RAPP | Sell | 2,421 | $30.04 | $73K | −7.2% | CEO | |
Dec 17, 2025 | RAPP | Sell | 515 | $31.04 | $16K | −1.6% | CEO | |
Dec 17, 2025 | RAPP | Sell | 2,441 | $28.84 | $70K | −0.4% | CEO | |
Dec 17, 2025 | RAPP | Sell | 2,792 | $30.04 | $84K | −0.5% | CEO | |
Nov 17, 2025 | RAPP | Sell | 2,242 | $24.91 | $56K | −5.5% | CEO | |
Nov 17, 2025 | RAPP | Sell | 2,841 | $25.44 | $72K | −7.3% | CEO | |
Nov 17, 2025 | RAPP | Sell | 3,056 | $25.43 | $78K | −0.5% | CEO | |
Nov 17, 2025 | RAPP | Sell | 2,777 | $24.92 | $69K | −0.5% | CEO | |
Oct 15, 2025 | RAPP | Sell | 4,328 | $25.75 | $111K | −9.4% | CEO | |
Oct 15, 2025 | RAPP | Sell | 755 | $26.17 | $20K | −1.8% | CEO | |
Oct 15, 2025 | RAPP | Sell | 4,647 | $25.72 | $120K | −0.8% | CEO | |
Oct 15, 2025 | RAPP | Sell | 1,186 | $26.14 | $31K | −0.2% | CEO | |
Sep 17, 2025 | RAPP | Sell | 34,885 | $26.30 | $918K | −42.7% | CEO | |
Sep 17, 2025 | RAPP | Sell | 700 | $27.04 | $19K | −1.5% | CEO | |
Sep 17, 2025 | RAPP | Sell | 39,435 | $26.30 | $1.0M | −6.3% | CEO | |
Sep 17, 2025 | RAPP | Sell | 1,400 | $26.87 | $38K | −0.2% | CEO | |
Sep 4, 2025 | PCRX | Sell | 2,354 | $27.19 | $64K | −20.7% | Director |
Top Companies Traded
Other insiders at Rapport Therapeutics, Inc.
4 other tracked filers at RAPP.